Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Achonu, Camille ^a   Rosella, Laura ^a,d   Gubbay, Jonathan B ^a,e   Deeks, Shelley ^a,d   Rebbapragada, Anu ^a   Mazzulli, Tony ^a   Willison, Don ^a   Foisy, Julie ^a   McGeer, Allison ^d,f   Johnson, Ian ^a,d   LaFreniere, Marie ^a   Johnson, Caitlin ^a   Willmore, Jacqueline ^b   Yue, Carmen ^c   Crowcroft, Natasha S ^a,d,e  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b Ottawa Public Health   (Canada)

^c TORONTO PUBLIC HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; HUMAN CELL; INFECTION RISK; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROSPECTIVE STUDY; RISK FACTOR; SEASONAL VARIATION; SERODIAGNOSIS; SEROPREVALENCE; ADOLESCENT; EPIDEMIOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MIDDLE AGED; PANDEMIC; PATHOGENICITY; SEASON; STATISTICS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ONTARIO; PANDEMICS; RISK FACTORS; SEASONS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 81055129913     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026427     Document Type: Article

References (37)

1. The Ontario Agency for Health Protection and Promotion and the Ontario Ministry of Health and Long-Term Care (2009) Epidemiological summary of pandemic influenza A (H1N1) 2009 virus- Ontario, Canada, June 2009. Wkly Epidemiol Rec 84: 485-491.
2. Ontario Ministry of Health and Long-term Care (2010) The H1N1 Pandemic - How Ontario Fared: A Report by Ontario's Chief Medical Officer of Health. Available: http://www.health.gov.on.ca/en/public/publications/ministry_reports/cmoh_h1n1/cmoh_h1n1_20100602.aspx. Accessed 2011 June 10.
3. Ontario Ministry of Health and Long-Term Care (2010) Ontario Influenza Bulletin Surveillance Week 4 (January 24, 2010-January 30, 2009). Available: http://www.health.gov.on.ca/english/providers/program/pubhealth/flu/flu_09/bulletins/flu_bul_01_20100205.pdf. Accessed 2011 June 10.
4. World Health Organization (2002) WHO manual on animal influenza diagnosis and surveillance. Available: http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf. Accessed 2011 June 10.
5. Skowronski DM, Hottes TS, Janjua NZ, Purych D, Sabaiduc S, et al. (2010) Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ 182: 1851-6.
6. McCullers JA, Van De Velde LA, Allison KJ, Branum KC, Webby RJ, et al. (2010) Recipients of Vaccine against the 1976 "Swine Flu" Have Enhanced Neutralization Responses to the 2009 Novel H1N1 Influenza Virus. CID 50: 1487-1492.
7. Potter CW, Oxford JS, (1979) Determinants of immunity to influenza infection in man. Br Med Bull 35: 69-75.
8. Papenburg J, Baz M, Hamelin MÈ, Rhéaume C, Carbonneau J, et al. (2011) Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus. Clin Vaccine Immunol 18 (3): 520-2.
9. Lerdsamran H, Pittayawonganon C, Pooruk P, Mungaomklang A, Iamsirithaworn S, et al. (2011) Serological Response to the 2009 Pandemic Influenza A (H1N1) Virus for Disease Diagnosis and Estimating the Infection Rate in Thai Population. PLoS ONE 6 (1): e16164 doi:10.1371/journal.pone.0016164.
10. Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, et al. (2010) The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 51: 1184-1191.
11. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, et al. (2010) Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One 5: e12562.
12. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, et al. (2010) Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One Oct 14;5: e13211.
13. Tian LL, Shi WX, Ying D, Pang XH, Peng Y, et al. (2010) Serologic survey of pandemic influenza A (H1N1 2009) in Beijing, China. Prev Med 52: 71-74.
14. Zimmer SM, Crevar CJ, Carter DM, Stark JH, Giles BM, et al. (2010) Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One 5: e11601.
15. Kelly H, Peck HA, Laurie KL, Wu P, Nishiura H, et al. (2011) The Age-Specific Cumulative Incidence of Infection with Pandemic Influenza H1N1 2009 Was Similar in Various Countries Prior to Vaccination. PLoS ONE 6 (8): e21828 doi:10.1371/journal.pone.0021828.
16. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100-1108.
17. Ross T, Zimmer S, Burke D, Crevar C, Carter D, et al. (2010) Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza. PLoS Curr Influenza RRN1148.
18. Waalen K, Kilander A, Dudman G, Krogh GH, Aune T, et al. (2010) High prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill 15: 19633.
19. Ikonen N, Strengell M, Kinnunen, Österlund LP, Pirhonen J, et al. (2010) High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 15: 19478.
20. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
21. McVernon J, Laurie K, Nolan T, Owen R, Irving D, et al. (2010) Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October-December 2009. Euro Surveill Oct 7;15: pii: 19678.
22. Chen MI, Lee VJ, Lim WY, Barr IG, Lin RT, et al. (2010) 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 303: 1383-1391.
23. Mahmud SM, Becker M, Keynan Y, Elliott L, Thompson LH, et al. (2010) Estimated cumulative incidence of pandemic (H1N1) influenza among pregnant women during the first wave of the 2009 pandemic. CMAJ 182: 1522-1524.
24. Troko J, Myles P, Gibson J, Hashim A, Enstone J, et al. (2011) Is public transport a risk factor for acute respiratory infection? BMC Infect Dis Jan 14;11: 16.
25. Al-Asmary S, Al-Shehri AS, Abou-Zeid A, Abdel-Fattah M, Hifnawy T, et al. (2007) Acute respiratory tract infections among Hajj medical mission personnel, Saudi Arabia. Int J Infect Dis May;11: 268-72.
26. Helferty M, Vachon J, Tarasuk J, Rodin R, Spika J, et al. (2010) Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ 182: 1981-1987.
27. Labrosse B, Tourdjman M, Porcher R, LeGoff J, de Lamballerie X, et al. (2010) Detection of extensive cross-neutralization between pandemic and seasonal A/H1N1 Influenza Viruses using a pseudotype neutralization assay. PLoS One 5: e11036.
28. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, et al. (2009) Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med Dec 17;361: 2405-13.
29. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, et al. (2010) Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 7: e1000258.
30. Foisy J, Rosella LC, Sanderson R, Hamid JS, Dhar B, et al. (2011) Self Reported Influenza A (H1N1) 2009 Vaccination Coverage for Ontario, Canada. Health Reports. Statistics Canada.Sept, 22:3. Available: http://www.statcan.gc.ca/pub/82-003-x/2011003/article/11541-eng.htm. Accessed 2011 September 30.
31. Roman F, Vaman T, Kafeja F, Hanon E, Van Damme P, (2010) AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age. CID 51: 668-677.
32. Foisy J, Rosella L, Lowcock B, Crowcroft N, (2011) Sensitivity and Specificity of pH1N1 Serological Tests. Am J Epidemiol 173 (suppl 11): S1-S316 doi:10.1093/aje/kwr181.
33. Wagar LE, Rosella L, Crowcroft N, Lowcock B, Drohomyrecky PC, et al. (2011) Humoral and Cell-Mediated Immunity to Pandemic H1N1 Influenza in a Canadian Cohort One Year Post-Pandemic: Implications for Vaccination. Submitted to PLoS ONE.
34. Ontario Agency for Health Protection and Promotion (2010) Ontario Agency for Health Protection and Promotion: Laboratory Pandemic Influenza Surveillance Report: April 5, 2010. Available: http://www.oahpp.ca/resources/documents/reports/labratorysurveillancereports/100405%20OAHPP%20Weekly%20Laboratory%20Surveillance%20Report.pdf. Accessed 2011 June 10.
35. Health Analytics Branch, Ontario Ministry of Health and Long-term Care (2007) Population Estimates [2007], IntelliHEALTH Ontario.
36. Statistics Canada. Profile- Ontario (table). Provincial and Territorial Profiles, 2006 Census of Population, Statistics Canada catalogue no. 92-591-XWE. Available: http://www12.statcan.gc.ca/census-recensement/2006/dp-pd/prof/92-591/index.cfm?Lang=E Accessed 2011 September 30.
37. (6011) Statistics Canada. Occupation- National Occupational Classification for Statistics 2006 (720), Class of Worker (6) and Sex (3) for the Labour Force 15 Years and Over of Canada, Provinces, Territories, Census Metropolitan Areas and Census Agglomerations, 2006 Census- 20% Sample Data, Statistics Canada Catalogue no. 97-559-XCB2006011. Available: http://www.statcan.gc.ca/bsolc/olc-cel/olc-cel?catno=97-559-XCB2006011&lang=eng Accessed 2011 September 30.